The Generalitat is promoting the creation of a business cluster for diagnostic cancer imaging.

VALENCIA (EP). Regional Minister of Industry, Felipe Carrascoannounced that the Generalitat will support the creation of a business cluster on diagnostic cancer imaging “with the aim of leading the work and research related to the European Cancer Imaging Initiative in the Valencian Community.”

In this regard, he emphasized that the Ministry of Innovation, Industry, Trade and Tourism will co-finance in the amount of 1.8 million euros the participation of the Valencian Community in the European project EUCAIM.

The project, created as part of the European Cancer Imaging Initiative, aims to apply technologies such as imaging and artificial intelligence to cancer treatment and care, the Generalitat said in a statement.

“EUCAIM,” he continued, “has research groups from the Health Research Institute of La Fe (HULAFE), the Polytechnic University of Valencia (UPV) and the University of Valencia (UV),” he noted and emphasized that “we are now talking about encouraging the creation of spin-off companies from universities that are also working in this area, and encouraging other companies to join forces and join the medical imaging ecosystem.”

According to Felipe Carrasco, the Department of Innovation “will support Valencian companies leading the European initiative against cancer.” “In addition, in accordance with the policies pursued by the Valencian Government, we are betting that the necessary conditions will be created to strengthen the competitiveness of those who exist and attract others to join and ultimately create the Image Cancer cluster in the Valencian Community” , he added.

“We must ensure that precision medicine researchers are joined by the efforts of companies related to bioengineering, cybersecurity, artificial intelligence and all those who are able to apply various advanced technologies in the treatment and cure of cancer,” he emphasized.

The Regional Minister of Industry emphasized that “EUCAIM plans to make cancer imaging data available to the AI ​​Health Testing and Experimentation Center established under the DIGITAL program.” “This will allow small and medium-sized companies that have developed artificial intelligence solutions for cancer treatment to test them in real-world conditions,” he said.

“It is important to consider that clinical imaging companies using artificial intelligence are revolutionizing the medical field by providing advanced solutions for diagnosis and treatment. These companies, with their very high added value, play a crucial role in research by facilitating the analysis of large data sets and the identification of relevant trends and patterns,” concluded Carrasco.

European Cancer Imaging Initiative

The European Cancer Imaging Initiative aims to promote innovation and the adoption of digital technologies in cancer treatment and care. Thus, patients with this pathology can achieve more accurate and faster clinical decision-making, diagnosis, treatment and prescribing prognostic drugs.

The EUCAIM project brings together organizations and expert personnel in disciplines as diverse as radiology, oncology, data management, computational science, ethics, law or artificial intelligence, with the goal of creating an oncology imaging infrastructure with more than 60 million data points from more than 100,000 patients. .

This data will allow for deeper analysis of images, extracting important information for diagnosing diseases without the need for biopsies, using less invasive methods for each patient and offering the best treatment for any type of tumor.

The project has global funding of €35 million and involves 79 partners from 14 European Union countries. Of the 18 Spanish organizations working on the project, three represent the Valencian Community.